Noticias y Actividades de Norgine France

Norgine France pertenece a Norgine. Norgine tiene presencia directa en 3 países.

Fusión, adquisición y financiación con participación de Norgine.

• Norgine acaba de anunciar una recaudación de fondos de 67 millones de dólares. (publicado el 26 de marzo de 2026).

Ver el organigrama con sus 7 ejecutivos principales

Biografías más buscadas en Norgine France

• Cyril Tavier, General Manager
• Léa Furlan, Director of Human Resources
• Valérie Cohen-Smadja, Head of Commercial

Recientes movimientos de ejecutivos en Norgine France

• Valérie Cohen-Smadja que ha sido National Sales Director, ha ascendido a Head of Commercial  (noticia publicada el 26 de marzo de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en Norgine France.

Norgine tiene 1.913 competidores entre los que se incluyen Sanofi (Francia), Eli Lilly (Estados Unidos) y Moderna (Estados Unidos).

Popular M&A news in Farmacia

• Corden Pharma has announced the acquisition of AmbioPharm  (publicado el 5 de junio de 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (publicado el 4 de junio de 2026).
• Contraline acaba de anunciar una recaudación de fondos de 93 millones de dólares. (publicado el 3 de junio de 2026).

Otros contactos sugeridos en el sector Farmacia

• Joaquin Duato - Chief Executive Officer and Chairman of the Board en Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board en Abbott
• Jonathan Leff - Director en Larimar Therapeutics

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Norgine France

• Norgine B.V. submits Marketing Authorisation Application via Project Orbis for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma - Norgine
• Norgine receives positive CHMP opinion recommending approval of NPJ5008 (dantrolene sodium hemiheptahydrate) for the treatment of malignant hyperthermia - Norgine
• Norgine Announces Appointment of New CEO Janneke van der Kamp - Norgine
• Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand - Norgine
• Pedmarqsi® (anhydrous sodium thiosulfate) recommended by NICE for patients 1 month to 17 years of age in England and Wales for the prevention of cisplatin-induced hearing loss - Norgine
• European study highlights need to improve the quality of conversations about induction of labour (IoL) in  clinical settings - Norgine
• Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer - Norgine
• NORGINE LAUNCHES ZIVEREL® IN AUSTRIA, BELGIUM, LUXEMBOURG AND SWITZERLAND - NorgineNORGINE LAUNCHES ZIVEREL® IN AUSTRIA, BELGIUM, LUXEMBOURG AND SWITZERLAND - Norgine
• LYMPHOSEEK®▼ (99mTc-tilmanocept) LAUNCHES IN EUROPE - NorgineLYMPHOSEEK®▼ (99mTc-tilmanocept) LAUNCHES IN EUROPE - Norgine
• NORGINE B.V. ACQUIRES AZANTA A/S, STRENGTHENING ITS POSITION AS A LEADING EUROPEAN SPECIALIST PHARMACEUTICAL COMPANY - NorgineNORGINE B.V. ACQUIRES AZANTA A/S, STRENGTHENING ITS POSITION AS A LEADING EUROPEAN SPECIALIST PHARMACEUTICAL COMPANY - Norgine
• View more press releases Close

Redes sociales sobre Norgine France

• Norgine France en Wikipedia, Google News y Yahoo Finance
• Norgine France en LinkedIn, Twitter y YouTube